Selective inhibitors of fibroblast activation protein (FAP) with a xanthine scaffold

about

Fibroblast activation protein-α in fibrogenic disorders and cancer: more than a prolyl-specific peptidase?

P2860

Q47922336-2C6040B5-855F-49C6-B824-407F562A3923

P2860

Selective inhibitors of fibroblast activation protein (FAP) with a xanthine scaffold

Item

http://www.wikidata.org/entity/Q58864169

description

article

@en

im Januar 2014 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2014

@uk

name

Selective inhibitors of fibroblast activation protein (FAP) with a xanthine scaffold

@en

Selective inhibitors of fibroblast activation protein

@nl

type

Item

label

Selective inhibitors of fibroblast activation protein (FAP) with a xanthine scaffold

@en

Selective inhibitors of fibroblast activation protein

@nl

prefLabel

Selective inhibitors of fibroblast activation protein (FAP) with a xanthine scaffold

@en

Selective inhibitors of fibroblast activation protein

@nl

P1476

Selective inhibitors of fibroblast activation protein (FAP) with a xanthine scaffold

@en

P2093

Jonathan D. Cheng

http://www.w3.org/2001/XMLSchema#string

Jurgen Joossens

http://www.w3.org/2001/XMLSchema#string

Koen Jansen

http://www.w3.org/2001/XMLSchema#string

Leen Heirbaut

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers

Rationale behind targeting fibroblast activation protein-expressing carcinoma-associated fibroblasts as a novel chemotherapeutic strategy

8-(3-(R)-aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydropurine-2,6-dione (BI 1356), a highly potent, selective, long-acting, and orally bioavailable DPP-4 inhibitor for the treatment of type 2 diabetes

Novel heterocyclic DPP-4 inhibitors for the treatment of type 2 diabetes

Identification of selective and potent inhibitors of fibroblast activation protein and prolyl oligopeptidase

Structural and kinetic analysis of the substrate specificity of human fibroblast activation protein alpha

Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers.

Rigidity and flexibility of dipeptidyl peptidase IV: crystal structures of and docking experiments with DPIV.

Fibroblast activation protein is expressed by rheumatoid myofibroblast-like synoviocytes

Fibroblast activation protein and chronic liver disease.

P304

1700-1707

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1039/C4MD00167B

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

Selective inhibitors of fibroblast activation protein (FAP) with a xanthine scaffold

about

P2860

P2860

Selective inhibitors of fibroblast activation protein (FAP) with a xanthine scaffold

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577